A Simulation Study of Power in Thorough QT/QTc Studies and a Normal Approximation for Planning Purposes-Reference-Cited by-同舟云学术

A Simulation Study of Power in Thorough QT/QTc Studies and a Normal Approximation for Planning Purposes

Published:2005-10 Issue:4 Volume:39 Page:447-455
ISSN:0092-8615
Container-title:Drug Information Journal
language:en
Short-container-title:Drug Information J

Author:

Hosmane Balakrishna,Locke Charles

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug Guides,Pharmacology (nursing)

Link

http://link.springer.com/content/pdf/10.1177/009286150503900411.pdf

Reference9 articles.

1. Moss AJ, Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B–25B.

2. Casella G, Berber R. Statistical Inference. Pacific Grove, CA: Wadsworth: 2002.

3. International Conference on Harmonisation. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs, E14. Step 4 of the ICH Process. 12 May 2005. Available at: https://doi.org/wwwwww.ich.org.

4. Fridericia LS, Die sytolendauer in elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand. 1920;53:469–486.

5. SAS/ STAT Software. Cary, NC: SAS Institute; 2004.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure–Response Analysis;Clinical and Translational Science;2020-03-19

2. Detection of QTc Effects in Small Studies-Implications for Replacing the Thorough QT Study;Annals of Noninvasive Electrocardiology;2014-11-04

3. Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single‐center, phase I, randomized, four‐way crossover study;The Journal of Clinical Pharmacology;2013-11-16

4. References;Design and Analysis of Clinical Trials;2013-11-08

5. The Joint Modeling of Drug and Positive Control Effects to Estimate Sample Size and Power in Crossover “Thorough” QT/QTc Studies;Journal of Biopharmaceutical Statistics;2013-06-20